Results 11 to 20 of about 9,727 (175)

Urate-lowering therapy for patients with gout on hemodialysis. [PDF]

open access: yesInt J Rheum Dis, 2022
AbstractObjectiveGout is the most common form of inflammatory arthritis and is caused by deposition of monosodium urate crystals resulting from a high burden of uric acid (UA). High UA burden also has been associated with increased morbidity and mortality in the general population and progression to chronic kidney disease.
Alkilany R, Einstadter D, Antonelli M.
europepmc   +3 more sources

Spinal gout recovery with urate-lowering therapy: A case report. [PDF]

open access: yesClin Case Rep
Key Clinical Message The occurrence of spinal gout resulting in erosion of the superior articular process in patients with low back pain is uncommon, potentially leading to misdiagnosis and inappropriate treatment. Urate‐lowering therapy may be beneficial in improving joint destruction and bone erosion, as evidenced by our case.
Huo K   +5 more
europepmc   +4 more sources

Prophylaxis for acute gout flares after initiation of urate-lowering therapy [PDF]

open access: yesRheumatology, 2014
This review summarizes evidence relating to prophylaxis for gout flares after the initiation of urate-lowering therapy (ULT). We searched MEDLINE via PubMed for articles published in English from 1963 to 2013 using MEsH terms covering all aspects of prophylaxis for flares.
Augustin, Latourte   +2 more
openaire   +4 more sources

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review. [PDF]

open access: yesPharmaceuticals (Basel), 2023
Tabi-Amponsah AD   +5 more
europepmc   +2 more sources

Cardiac and renal protective effects of urate-lowering therapy [PDF]

open access: yesRheumatology, 2017
Patients with gout often have co-morbidities such as cardiovascular disease, renal failure and metabolic syndrome components. Some studies, but not all, have suggested that hyperuricaemia and gout are associated with increased risk of myocardial infarction, renal failure and death primarily because of increased risk of cardiovascular events. Therefore,
Pascal, Richette   +2 more
openaire   +2 more sources

Urate-lowering therapy and kidney function

open access: yesModern Rheumatology Journal, 2023
Chronic hyperuricemia (CH) and gout are independent risk factors for decreased kidney function. In the last decade, evidence was accumulating that urate-lowering therapy may be an effective method of slowing down the progression of CH and gout-mediated renal failure.
openaire   +2 more sources

Bariatric surgery as urate-lowering therapy in severe obesity [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2014
Gout represents a metabolically driven inflammatory arthropathy, which could be substantially influenced by adiposity and lifestyle risk factors. As such, influenced by the trends in lifestyle factors associated with Westernisation,1 ,2 gout prevalence has increased in the last few decades worldwide (eg, 3.9% of US adults (8.3 million) in 2007–20083).4
Hyon K, Choi, Yuqing, Zhang
openaire   +2 more sources

Urate-lowering therapy for heart failure

open access: yesModern Rheumatology Journal, 2019
Heart failure (HF) is one of the major public health problems in developed countries. Hyperuricemia (HU) is often found in patients with chronic HF (CHF) and is a well-known independent predictor for mortality and re-hospitalization for the progression of HF.
O. V. Zhelyabina, M. S. Eliseev
openaire   +3 more sources

Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort [PDF]

open access: yes, 2017
Gout is characterized by recurrent episodes of acute inflammation of joint structures, called gout flares, and flares are commonly treated with nonsteroidal anti-inflammatory drugs (NSAIDs).
Pérez Ruiz, Fernando
core   +3 more sources

Acute kidney injury in critically ill cancer patients : an update [PDF]

open access: yes, 2016
Patients with cancer represent a growing group among actual ICU admissions (up to 20 %). Due to their increased susceptibility to infectious and noninfectious complications related to the underlying cancer itself or its treatment, these patients ...
Benoit, Dominique   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy